# ABL BIO USA, Inc. — Form D

ABL BIO USA, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-07. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-09-07
- Form: D
- Accession: 0001991318-23-000002
- Industry: Biotechnology
- Exemptions: 04, 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 1
- Date of first sale: 2023-07-25
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-491576

## Issuer

- Name: ABL BIO USA, Inc.
- CIK: 0001991318
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2022
- Address: 3223 HANOVER ST, PALO ALTO, CA, 94304
- Phone: 7347073715

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Jae Cheon Lee | Director | Palo Alto, CA |
| Jae Cheon Lee | Executive Officer | Palo Alto, CA |

## More

- [CIK 1991318 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1991318&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001991318-23-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.